This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking ...

Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Stock analysts at Alliance Global Partners dropped their FY2025 EPS estimates for shares of Cresco Labs in a note issued to investors on Wednesday, ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands ...

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular ...

"We entered 2025 with the flexibility and financial strength needed to navigate market volatility, complete our debt refinancing, and remain both strategic and patient as we invest thoughtfully for ...

Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Analysts at Cormark reduced their FY2025 earnings estimates for shares of Cresco Labs in a research report issued to clients and investors on Monday, ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most ...

Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.16 per share a year ago. These figures ...

Cresco Labs Q4 revenue is $175.91M, surpassing estimates of $172.13M. Adjusted EBITDA hit $42M with a 24% margin. Gross margin drops to 47.8% from 51.1%, while operating profit declines to $19.41M.

"In Q2, we delivered solid performance in line with guidance, maintained our market share in a highly competitive environment, and continued to drive cash flow through operational discipline.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward ...

Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.02 per share a year ago. These figures ...